vaccines

News

Pfizer plans considerable 2023 Comirnaty markup

With US government supplies of Covid vaccines predicted to run out in the first quarter of 2023, it has been revealed that Pfizer/BioNTech

Views & Analysis

GSK continues campaign for greater adult immunisation covera...

The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this.

News

group of chemical scientists working at the laboratory.

BMA responds to ABPI report, warns UK losing research leader...

In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a sharp decline (41%) in clinical trials initiated by the UK in the period 2017 to 2021,

R&D

Reconfiguring COVID and influenza vaccines for long-term eff...

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company's breakthrough vaccine technology, oligoDOM, and how it's driving the development of new influenza and SARS-CoV-2 vacc

R&D